The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

11 articles for N Jain


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Synthesis and biological evaluation of podophyllotoxin congeners as tubulin polymerization inhibitors.EBI
National Institute of Pharmaceutical Education and Research (NIPER)
Synthesis and biological evaluation of 4-aza-2,3-dihydropyridophenanthrolines as tubulin polymerization inhibitors.EBI
Csir-Indian Institute of Chemical Technology
Synthesis and SAR study of novel pseudo-steroids as potent and selective progesterone receptor antagonists.EBI
Johnson and Johnson Pharmaceutical Research and Development
Alpha,beta-methylene-2'-deoxynucleoside 5'-triphosphates as noncleavable substrates for DNA polymerases: isolation, characterization, and stability studies of novel 2'-deoxycyclonucleosides, 3,5'-cyclo-dG, and 2,5'-cyclo-dT.EBI
University of Rhode Island
Parallel synthesis and SAR study of novel oxa-steroids as potent and selective progesterone receptor antagonists.EBI
Johnson and Johnson Pharmaceutical Research and Development
Synthesis and identification of novel oxa-steroids as progesterone receptor antagonists.EBI
Johnson and Johnson Pharmaceutical Research and Development
Identification and structure-activity relationships of chromene-derived selective estrogen receptor modulators for treatment of postmenopausal symptoms.EBI
Johnson & Johnson Pharmaceutical Research & Development
Synthesis, structure-activity relationship and in vivo antiinflammatory efficacy of substituted dipiperidines as CCR2 antagonists.EBI
Johnson & Johnson Pharmaceutical Research and Development
Novel chromene-derived selective estrogen receptor modulators useful for alleviating hot flushes and vaginal dryness.EBI
Johnson & Johnson Pharmaceutical Research & Development
Multiple weak intercalation as a strategy for the inhibition of polymerases.EBI
University of Missouri-Kansas City
Inhibition of therapeutically important polymerases with high affinity bis-intercalators.EBI
University of Missouri